Stroke Trial, Recruiting NCT07439367 Sponsor: School of Health Sciences Geneva Condition: Stroke
Back to Stroke

Stroke Trial, Recruiting

NCT07439367
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

For people who have had a stroke:

  • Adults aged 18 or older
  • People who have had their first-ever stroke (either a blockage or a bleed in the brain)
  • At least 6 months have passed since the stroke
  • Weakness or reduced movement affecting one arm or hand (but not both sides)
  • Arm movement ability falling within a specific mid-range on a standard assessment scale called the Fugl-Meyer Upper Extremity scale (confirm with trial site)
  • Muscle stiffness in the elbow, wrist, or fingers is mild or absent, as measured by a standard clinical scale (confirm with trial site)
  • Enough muscle strength in the shoulder, upper arm, and wrist to reach a score of at least 3 out of 5 on a standard strength test (confirm with trial site)
  • Able to understand and follow the study instructions
  • Willing to provide written consent to participate

For healthy participants (no history of stroke):

  • Adults aged 18 or older
  • No history of any neurological disease
  • Able to understand and follow the study instructions
  • Willing to provide written consent to participate

Who may not be able to join:

For people who have had a stroke:

  • People who have a second stroke during the study period
  • People who have received botulinum toxin (Botox) injections within the 3 months before the study starts
  • People with a history of epileptic seizures
  • People with any metal object near the area where the brain stimulation would be applied
  • People with implanted devices such as a pacemaker or neurostimulator that are not compatible with a brain stimulation technique called TMS (confirm with trial site)
  • People with serious conditions affecting the arm, such as major joint, rheumatic, or nerve and muscle diseases
  • People who are pregnant
  • People experiencing confusion or significantly reduced alertness
  • People unable to take part in one-hour treatment sessions
  • People unable to follow study procedures for any reason, such as a language barrier, a psychological condition, or dementia
  • People with a current or past history of substance abuse, including heavy alcohol use
  • People who have taken part in another interventional clinical trial within 30 days before enrolling

For healthy participants:

  • People with a serious muscle, joint, or neurological condition affecting their non-dominant arm
  • People who are pregnant
  • People experiencing confusion or significantly reduced alertness
  • People unable to take part in one-hour treatment sessions
  • People unable to follow study procedures
  • People with a current or past history of substance abuse, including heavy alcohol use
  • People who have taken part in another interventional clinical trial within 30 days before enrolling

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 21 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +41792633543

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
School of Health Sciences Geneva
Registry
ClinicalTrials.gov
Start date
5 September 2025
Est. completion
31 August 2026

Where this trial is recruiting

🇨🇭 Switzerland

Primary endpoints

Change in Global Motor Performance Index (Baseline to Day 10)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov